Literature DB >> 20472895

An Akt- and Fra-1-dependent pathway mediates platelet-derived growth factor-induced expression of thrombomodulin, a novel regulator of smooth muscle cell migration.

Aruna Ramachandran1, Sandeep A Ranpura, Edward M Gong, Michelle Mulone, Glenn M Cannon, Rosalyn M Adam.   

Abstract

Overdistension of hollow organs evokes pathological changes characterized by smooth muscle remodeling. Mechanical stimuli induce smooth muscle cell (SMC) growth through acute activation of signaling cascades and by increased expression of soluble mitogens. Physical forces have also been implicated in ligand-independent activation of receptor tyrosine kinases, including the platelet-derived growth factor (PDGF) receptor, although the extent to which this occurs in intact tissue is unknown. Previously, we implicated Akt and activator protein-1 (AP-1) as mediators of growth and gene expression in SMC exposed to cyclic stretch or PDGF. Here we show that bladder wall distension leads to PDGFR activation and identify thrombomodulin (TM) as an Akt and AP-1 target in SMC. We demonstrate that TM, also induced by bladder stretch injury, is regulated at the transcriptional level by the AP-1 components c-jun and Fra1. Mutation of an AP-1 motif at -2010/-2004 abolished both AP-1 binding and PDGF responsiveness of the TM promoter. Fra1 silencing diminished PDGF-induced TM expression and SMC cell cycle transit. In contrast, TM knockdown did not affect cell growth but attenuated PDGF-stimulated SMC migration. Taken together, these results reveal new facets of TM regulation in SMC and provide the first demonstration of a role for endogenous TM in PDGF-induced cell migration. Moreover, TM induction on bladder injury suggests that it may be a biomarker for pathological smooth muscle remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472895      PMCID: PMC2893656          DOI: 10.2353/ajpath.2010.090772

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Regulation of PDGF and its receptors in fibrotic diseases.

Authors:  James C Bonner
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

2.  Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events.

Authors:  R M Baxter; J P Secrist; R R Vaillancourt; A Kazlauskas
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

3.  Mechanical stretch augments PDGF receptor beta expression and protein tyrosine phosphorylation in pulmonary artery tissue and smooth muscle cells.

Authors:  Y Tanabe; M Saito; A Ueno; M Nakamura; K Takeishi; K Nakayama
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Evidence of human thrombomodulin domain as a novel angiogenic factor.

Authors:  Chung-Sheng Shi; Guey-Yueh Shi; Yi-Sheng Chang; Huai-Song Han; Cheng-Hsiang Kuo; Che Liu; Huey-Chun Huang; Yu-Jia Chang; Pin-Shern Chen; Hua-Lin Wu
Journal:  Circulation       Date:  2005-03-28       Impact factor: 29.690

5.  Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells.

Authors:  Huiqing Cao; Nagadhara Dronadula; Gadiparthi N Rao
Journal:  Am J Physiol Cell Physiol       Date:  2005-09-07       Impact factor: 4.249

6.  Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.

Authors:  H T Nguyen; R M Adam; S H Bride; J M Park; C A Peters; M R Freeman
Journal:  Am J Physiol Cell Physiol       Date:  2000-10       Impact factor: 4.249

7.  Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells.

Authors:  I-Chung Lo; Tsun-Mei Lin; Ling-Hui Chou; Shu-Lin Liu; Li-Wha Wu; Guey-Yueh Shi; Hua-Lin Wu; Meei Jyh Jiang
Journal:  Cardiovasc Res       Date:  2008-12-17       Impact factor: 10.787

8.  Promoter specificity and biological activity of tethered AP-1 dimers.

Authors:  Latifa Bakiri; Koichi Matsuo; Marta Wisniewska; Erwin F Wagner; Moshe Yaniv
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation.

Authors:  D von der Ahe; C Nischan; C Kunz; J Otte; U Knies; H Oderwald; B Wasylyk
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

10.  Upregulation of both PDGF-BB and PDGF-BB receptor in human bladder fibroblasts in response to physiologic hydrostatic pressure.

Authors:  Cem Akbal; Sang Don Lee; Chaeyong Jung; Richard Rink; Martin Kaefer
Journal:  J Pediatr Urol       Date:  2006-08-07       Impact factor: 1.830

View more
  15 in total

1.  AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.

Authors:  Wanmu Xie; Lin Zhang; Wei Luo; Zhenguo Zhai; Chen Wang; Ying H Shen
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

2.  Deletion of neuropilin 2 enhances detrusor contractility following bladder outlet obstruction.

Authors:  Evalynn Vasquez; Vivian Cristofaro; Stefan Lukianov; Fiona C Burkhard; Ali Hashemi Gheinani; Katia Monastyrskaya; Diane R Bielenberg; Maryrose P Sullivan; Rosalyn M Adam
Journal:  JCI Insight       Date:  2017-02-09

3.  FOSL1 is integral to establishing the maternal-fetal interface.

Authors:  Lindsey N Kent; M A Karim Rumi; Kaiyu Kubota; Dong-Soo Lee; Michael J Soares
Journal:  Mol Cell Biol       Date:  2011-09-26       Impact factor: 4.272

4.  Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Authors:  Dolores Di Vizio; Matteo Morello; Andrew C Dudley; Peter W Schow; Rosalyn M Adam; Samantha Morley; David Mulholland; Mirja Rotinen; Martin H Hager; Luigi Insabato; Marsha A Moses; Francesca Demichelis; Michael P Lisanti; Hong Wu; Michael Klagsbrun; Neil A Bhowmick; Mark A Rubin; Crislyn D'Souza-Schorey; Michael R Freeman
Journal:  Am J Pathol       Date:  2012-09-27       Impact factor: 4.307

Review 5.  Dynamic reciprocity in cell-scaffold interactions.

Authors:  Joshua R Mauney; Rosalyn M Adam
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

6.  Increased smooth muscle contractility in mice deficient for neuropilin 2.

Authors:  Diane R Bielenberg; Abhishek Seth; Akio Shimizu; Kristine Pelton; Vivian Cristofaro; Aruna Ramachandran; Bernadette M M Zwaans; Cheng Chen; Ramaswamy Krishnan; Meetu Seth; Lin Huang; Seiji Takashima; Michael Klagsbrun; Maryrose P Sullivan; Rosalyn M Adam
Journal:  Am J Pathol       Date:  2012-06-09       Impact factor: 4.307

7.  FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle.

Authors:  Aruna Ramachandran; Edward M Gong; Kristine Pelton; Sandeep A Ranpura; Michelle Mulone; Abhishek Seth; Pablo Gomez; Rosalyn M Adam
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

8.  Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.

Authors:  Shyama Majumdar; Edward M Gong; Dolores Di Vizio; Jonathan Dreyfuss; David J Degraff; Martin H Hager; Peter J Park; Joaquim Bellmunt; Robert J Matusik; Jonathan E Rosenberg; Rosalyn M Adam
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

9.  Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes.

Authors:  Zongwei Wang; Zhiyong Cheng; Vivian Cristofaro; Jijun Li; Xingyuan Xiao; Pablo Gomez; Rongbin Ge; Edward Gong; Klemen Strle; Maryrose P Sullivan; Rosalyn M Adam; Morris F White; Aria F Olumi
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

10.  JunB mediates basal- and TGFβ1-induced smooth muscle cell contractility.

Authors:  Aruna Ramachandran; Samudra S Gangopadhyay; Ramaswamy Krishnan; Sandeep A Ranpura; Kavitha Rajendran; Sumati Ram-Mohan; Michelle Mulone; Edward M Gong; Rosalyn M Adam
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.